|
Rachel
Stern, MS, RD, CNS is a nutritionist for the North Jersey Community
Research Initiative in Newark, NJ. Previous positions include the Women's
Infectious Disease Clinic at UMDNJ in Newark, WIC, Head Start, Blue Cross/Blue
Shield, Columbia University Institute of Reproduction, Research Corporation,
and University of Wisconsin. Sharon
Ann Meyer, AS, AA, DTR, is the President of HIV ReSources, Inc., Editor-In-Chief
of the HIV Nutrition Update, Nutrition Editor for NUMEDX
journals and co-author of HIV
Medications Food Interactions (And So Much More).
Coenzyme Q10 (CoQ10)
is among the most widely recommended complementary supplements for HIV
disease. Although the substance has been well studied, and there has been
considerable research on its use in preventing or treating several health
conditions, published studies of HIV and CoQ10 have been disappointingly
few. Proponents of the coenzyme for HIV infection base their recommendations
on information from manufacturers’ promotional materials and anecdotal
reports. HIV-positive people use CoQ10 despite the lack of well-designed
clinical trials documenting its effectiveness in the treatment of HIV infection.
This paper reviews CoQ10's potential role as a therapy, specifically in
HIV/AIDS-infection, and also gives an overview of some popular CoQ10 uses
by the general public.
Editors’ Note
This issue features an
article on coenzyme Q10; another expansion of a literature review completed
by members of the Macronutrients, Micronutrients, and Non-Essential Dietary
Supplements subgroup of the National HIV Nutrition Guidelines Working Group.
Other subjects covered by the national group are in the April 1st Clinical
Infectious Diseases supplement. We highlight a nutrition program in
Vermont, information on fatty liver and controlling liver enzymes,
PEG-Intron used for hepatitis, and offer resources for clinicians and clients. |
|
